News & Updates
Showing Obstetrics & Gynaecology articles
Showing

MIRASOL PRO data boost mirvetuximab soravtansine potential in FRα-positive ovarian cancer
Patient-reported outcomes (PROs) from the phase III MIRASOL trial underpin the potential of the antibody drug conjugate mirvetuximab soravtansine (MIRV) to improve health-related quality of life (HRQoL) in women with folate receptor-alpha positive platinum-resistant ovarian cancer (FRα-positive PROC) as opposed to investigator’s choice of chemotherapy.

Dostarlimab-chemo a new SoC for endometrial cancer?
In the second interim analysis of part 1 of the phase III ENGOT-EN6-NSGO/GOG-3031/RUBY trial, dostarlimab plus carboplatin/paclitaxel (CP) chemotherapy delivered a significant survival benefit in women with primary advanced or recurrent endometrial cancer.

Improved cervical screening uptake among local South Asian women following CUHK training
Expansion of a territory-wide cervical screening programme to train a group of local South Asian women has enabled education regarding cervical cancer and screening services among their peers, and considerably improved screening uptake.

Vertical COVID-19 transmission low in SG
Transmission of SARS-CoV-2 infection from mothers to newborns appears to be rare in a cohort study conducted by the KK Women’s and Children’s Hospital (KKH), Singapore General Hospital (SGH), and National University Hospital (NUH).





